Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 61Unknown 12Terminated 10Recruiting 4Active not recruiting 2Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Multiple Myeloma 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms, Plasma Cell 2Lymphoma 2Immunoglobulin Light-chain Amyloidosis 2Triple Negative Breast Neoplasms 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Paraproteinemias 1Neoplasms 1Neoplasm, Residual 1Malignant Plasma Cell Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell 1Lung Neoplasms 1Leukemia, Plasma Cell 1Leukemia 1Hematologic Diseases 1Esophageal Stenosis 1Esophageal Neoplasms 1Corneal Diseases 1Breast Cancer Patients Treated With T-DXd 1Brain Neoplasms 1Blood Protein Disorders 1Ann Arbor Stage II Mantle Cell Lymphoma 1Amyloidosis 1

Interventions

venetoclax 4Cyclophosphamide 4fludarabine 3Azacitidine 3blinatumomab 2Whole-Body Irradiation 2Cytarabine 2Blood Specimen Collection 2pegaspargase 1etoposide phosphate 1capivasertib 1Vincristine 1Tretinoin 1Tissue Banks 1Tacrolimus 1Mycophenolic Acid 1Methotrexate 1Mercaptopurine 1Immunotherapy, Adoptive 1IPI-549 1Etoposide 1Drug Therapy, Combination 1Doxorubicin 1Dexamethasone 1Decitabine 1Calcium Dobesilate 1Busulfan 1Arsenic Trioxide 1Anthracyclines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Leukemia × Dexamethasone × Clear all
NCT07227584 2025-11-12

ALL Backbone in AYAs

Dana-Farber Cancer Institute

Phase 2 Not yet recruiting
67 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡